Nelson Steven H 4

What Happened
Steven H. Nelson, a Health Catalyst (HCAT) director, received an award of 154,808 restricted stock units (RSUs) on 2026-05-01. The Form 4 reports an acquisition price of $0.00 for the award (transaction code A). Each RSU represents a contingent right to one share of common stock and will convert to shares as the RSUs vest.

Key Details

• Transaction date: 2026-05-01; filing date: 2026-05-04 (Accession No. 0001320490-26-000002). No late-filing flag is shown in the report.
• Award size: 154,808 RSUs; reported acquisition price: $0.00 (grant value not specified on Form 4).
• Vesting: 33.33% vests on May 1, 2027; the remaining 66.67% vests in two equal annual installments thereafter (per footnote).
• Shares owned after transaction: not specified in the provided filing.
• Footnote: The award was granted under the 2019 Stock Option and Incentive Plan and Issuer’s Non-Employee Director Compensation Policy (see F1 for vesting schedule).

Context
This is an equity compensation award (not a market purchase or sale). RSU grants to non-employee directors are common as part of routine director compensation and do not by themselves indicate a buy/sell signal. The RSUs are contingent until they vest and convert to actual shares; any tax withholding or share withholding at vesting would be reported separately if it occurred.